DEA Archived Press Releases

Press Releases before January 20, 2025
660 Results - Showing 201 to 210
PRESS RELEASE

Drug Enforcement Administration announces creation of U.S. Postal Service drug-free stamp

WASHINGTON – The U.S Postal Service today revealed the “Drug Free USA Forever” stamp in conjunction with Red Ribbon Week, the nation’s oldest and largest drug use prevention awareness program. The stamp will be available for sale in October 2020. Earlier this year, DEA and the National Family Partnership submitted...
PRESS RELEASE

DEA and Local Partners Host 18th National Drug Takeback on October 26th from 10 a.m. – 2 p.m.

LOS ANGELES – Over the course of 17 prior events, the National Drug Take Back Day Initiative continues to remove ever-higher amounts of opioids and other medications from the nation’s homes, where they are vulnerable to misuse, theft or abuse by family members and visitors, including children and teens. In...
PRESS RELEASE

DEA announces additional regulatory steps to address opioid epidemic

WASHINGTON – The Drug Enforcement Administration today announced proposed regulations to improve DEA’s ability to oversee the production of dangerous drugs at the height of the national opioid crisis. This proposed regulation would further limit excess quantities of medications that might be vulnerable to diversion for illicit distribution and use...
PRESS RELEASE

Former Honduran congressman Tony Hernández convicted of conspiring to import cocaine into the United States and related firearms and false-statements offenses

NEW YORK – On October 18, DEA Special Operations Division Special Agent in Charge Wendy C. Woolcock and U.S. Attorney for the Southern District of New York Geoffrey S. Berman announced that on a jury returned a guilty verdict against Juan Antonio Hernández Alvarado, aka “Tony Hernández,” on all four...
PRESS RELEASE

DEA to accept electronic vaping devices and cartridges as part of National Prescription Drug Take Back Day

WASHINGTON – With robust public participation over the course of 17 prior events, the National Prescription Drug Take Back Day Initiative continues to remove ever-higher amounts of opioids and other medicines from the nation’s homes, where they are vulnerable to misuse, theft or abuse by family members and visitors, including...
PRESS RELEASE

DEA encourages communities nationwide to Go Red for Red Ribbon

WASHINGTON – Following the successful launch of the 2019 National Red Ribbon Campaign earlier this month with First Lady Melania Trump at the annual Red Ribbon Rally , DEA is encouraging communities nationwide to Go Red for Red Ribbon – an effort to continue the momentum and promote awareness of...
PRESS RELEASE

First Lady Melania Trump kicks off National Red Ribbon Week with DEA

WASHINGTON – First Lady Melania Trump today joined DEA Acting Administrator Uttam Dhillon to celebrate the official launch of the 2019 Red Ribbon campaign, dedicated to preserving the memory of DEA Special Agent Enrique “Kiki” Camarena – a DEA special agent who was kidnapped, tortured, and murdered in Mexico by...
PRESS RELEASE

Federal grand jury charges three men for distributing fentanyl-laced pills that caused death of rapper Mac Miller

LOS ANGELES – Three men were charged in a federal grand jury indictment that alleges they distributed narcotics, including counterfeit pharmaceutical pills, containing fentanyl that resulted in the overdose death of hip-hop artist Mac Miller. Cameron James Pettit, 28, of West Hollywood; Stephen Andrew Walter, 46, of Westwood; and Ryan...
PRESS RELEASE

DEA and FDA warn website operators illegally offering opioids for sale

WASHINGTON – The U.S. Drug Enforcement Administration and the U.S. Food and Drug Administration have issued warning letters to four website owners of rogue online pharmacies offering to distribute or dispense controlled substances, including opioids, and advertising their sale in violation of federal law. This is the first time the...
PRESS RELEASE

DEA proposes to control three precursor chemicals used to illicitly manufacture deadly fentanyl

WASHINGTON – In an effort to reduce the availability of deadly illegal fentanyl in America, the U.S. Drug Enforcement Administration has proposed to control three substances used by operators of clandestine laboratories to illicitly manufacture the deadly Schedule II controlled substance. Two Notices of Proposed Rulemaking were published in the...